Join us! November Journal Club This session will explore the lead article in our November issue, “ Safety of ovarian preservation for premenopausal patients with FIGO stage I grade 2 and 3 endometrioid endometrial adenocarcinoma, along with its accompanying editorial. When? Friday, November 18, from 11:00-11:45 AM CDT (6:00 PM CEST). Registration is not required. To join the November IJGC chat, simply use this Zoom link to join the journal club at the scheduled time. The featured discussants are Dr. Dimitrios Nasioudis, lead author of the article, who will be joined by IJGC Editor-in-Chief Dr. Pedro Ramirez and Social Media Editor Dr. Ane Gerda Zahl Eriksson. We strongly encourage you to join Drs. Nasioudis, Ramirez, and Eriksson—along with your colleagues from around the world—as they assess the article’s findings, evaluate their clinical significance, and consider their potential role in gynecological oncology.
If you would like to see your event on this calendar, please email firstname.lastname@example.org.
Events must be related to the field of gynecologic cancers with the target audience of clinicians, researchers, or advocates (patient/survivors/family members/caregivers).
Join IGCS and Dr. Robert Coleman for this exciting webinar!
Join IGCS and Dr. Mansoor Mirza for this exciting webinar! Supported in part by GSK.
Join us December 20th for the Radiation Oncology ECHO!
Multidisciplinary Approach to Treating Advanced Endometrial Cancer February 14 at 12:30 PM UTC See all time zones New drug combinations have emerged for the treatment management of advanced endometrial cancer. Learn the benefits of having your multidisciplinary team involved in the management of toxicities in these patients. Thanks to the support from Eisai, this webinar is complimentary for all attendees. Register Here
Join us! February Journal Club The lead article is: Role of Minimally Invasive Secondary Cytoreduction in Patients with Recurrent Ovarian Cancer by Carmine Conte and Giovanni Scambia When? Thursday, February 16, from 11:00-11:45 AM CDT (6:00 PM CEST). Registration is not required. To join the IJGC chat, simply use this Zoom link to join the journal club at the scheduled time. The featured discussants are Drs. Carmine Conte and Giovanni Scambia, authors of the article, who will be joined by IJGC Editor-in-Chief Dr. Pedro Ramirez and Social Media Editors Drs. Aarthi S. Jayraj and Andreina Fernandes . We strongly encourage you to join Drs. Conte, Scambia, Ramirez, Jayraj, and Fernandes —along with your colleagues from around the world—as they assess the article’s findings, evaluate their clinical significance, and consider their potential role in gynecological oncology.
Upcoming Free Webinar! IMPROVING ACCESS TO SCREENING TO PREVENT HPV-RELATED CANCER Live Event: Friday, March 3rd, 2023 at 16:00-17:00 CET (Geneva) The International Papillomavirus Society (IPVS) cordially invites you to participate in our live, free webinar on Friday, March 3rd, 2023 to commemorate International HPV Awareness Day Campaign 2023 and to celebrate the mobilization of effort around the world to eliminate HPV and prevent HPV-cancer. Join our panel of knowledge leaders from the world of clinical practice, policy and patient advocacy to explore strategies and priorities to advance access to screening as part of a global strategy to prevent HPV-related cancer. Each year roughly 600,000 people across the world are diagnosed with one of the six identified types of HPV-related cancer. Cervical cancer alone takes the lives of over 300,000 women per year, a statistic that is even more devastating because it is largely preventable. Screening is a critical cancer prevention tool and cervical screening is one of three pillars identified in the WHO global strategy to eliminate cervical cancer. However, there are significant gaps in access to screening - both domestically and globally. Delivering effective cervical screening programs and crucially, being able to follow up with effective preventive treatment, requires a level of health system development that poses particular challenges to healthcare systems particularly in low-income communities. Innovative